PERSPECTIVE THERAPEUTICS, INC. (CATX) Free cash flow 2016–2025
PERSPECTIVE THERAPEUTICS, INC. (CATX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$95.2MFY2025 · since FY2016: -$6.3M → -$95.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$95.2M | -31.0% |
| FY2024 | -$72.7M | -91.4% |
| FY2023 | -$38.0M | -255.6% |
| FY2022 | -$10.7M | -33.9% |
| FY2021 | -$8.0M | -147.9% |
| FY2020 | -$3.2M | +17.8% |
| FY2019 | -$3.9M | +28.7% |
| FY2018 | -$5.5M | +9.2% |
| FY2017 | -$6.0M | +3.4% |
| FY2016 | -$6.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CATX financial trends
CATX RevenueCATX Net incomeCATX Net marginCATX Gross profitCATX Gross marginCATX Operating incomeCATX Operating marginCATX Operating cash flowCATX Capital expendituresCATX Return on equityCATX Stock buybacksCATX Dividends paidCATX Total assetsCATX Total liabilitiesCATX Shareholders’ equityCATX overview →